ArticleFrontiers in genetics2026
Exploring prognostic genes related to lactylation and programmed cell death in pancreatic ductal adenocarcinoma: a comprehensive study combining bulk transcriptomics and experimental verification.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is a strong correlation between lactylation, programmed cell death, and the progression of cancer. This study aims to identify prognostic genes associated with lactylation and programmed cell death in pancreatic ductal adenocarcinoma (PDAC), providing new insights for risk stratification and therapeutic strategies. Methods: TCGA-PAAD, GSE62452, lactylation-related genes (LRGs), and programmed cell death-related genes (PCDRGs) were retrieved from relevant databases and references. Prognostic genes were identified through univariate Cox regression analysis, followed by random survival forest analysis for survival prediction. Subsequently, enrichment analysis, immune microenvironment analysis, drug sensitivity analysis, immunohistochemical analysis, and expression analysis of prognostic genes were conducted. Finally, the experimental verification was carried out in clinical samples. Results: In this investigation, two prognostic genes (HMGA1 and KIF2C) linked to lactylation and programmed cell death were identified, and a robust prognostic risk model was developed. Enrichment analysis results included Cell cycle, G2M checkpoint, Myogenesis, and Angiogenesis. Moreover, immature B cells and activated B cells demonstrated the strongest positive correlation (cor = 0.97, Conclusion: In the present investigation, two prognostic genes were identified, and subsequently, a predictive risk model was established, which may serve as a valuable reference for the clinical management of PDAC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.